HIV Transmission & Prevention Journal Articles

• Associations Between HIV, ART and Preterm Birth In what ways might HIV and antiretroviral exposure impact the risk for preterm birth?
  HIV Medicine, April 28, 2022
• Safety and Tolerability of Once Daily BIC/FTC/TAF for PEP Is this PEP regimen a safe and effective means of preventing HIV infection after high-risk sexual exposure?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, April 27, 2022
• Comorbidities in Women Living With HIV Gain a better understanding of the prevalence and impact of coexisting conditions among women living with HIV.
  HIV Medicine, April 21, 2022
• Integrating Services to Improve Care for Women With HIV Learn how integrating services could positively impact the quality of care for women living with HIV.
  HIV Medicine, April 14, 2022
• Lower Incidence of HIV-1 Blips During INSTI-Based ART A new study observes a lower number of viral blips during INSTI-based treatment compared with other ART regimens.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, March 30, 2022
• Alcohol, Smoking, Drug Use and HIV Virological Outcomes Might alcohol, cigarette and drug use impact ART adherence and virological outcomes among people living with HIV?
  HIV Medicine, March 17, 2022
• Outcomes of Inpatients With and Without HIV With COVID-19 Are there differences in COVID-19 outcomes between people with and without HIV?
  HIV Medicine, March 10, 2022
• Atazanavir With Cobicistat in Pregnant Women With HIV Is this ART regimen a safe HIV treatment during pregnancy?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, March 03, 2022
• Impact of COVID-19 on HIV Testing and Care Provision The significant impacts of the COVID-19 pandemic on access to HIV testing and treatment could have long-term consequences.
  HIV Medicine, February 24, 2022
• Disparities in Awareness of PreP Among Heterosexual Adults Heterosexual sex accounts for 23% of new HIV diagnoses, but this report shows that PrEP awareness among at-risk heterosexual adults is low, particularly among certain groups.
  Morbidity & Mortality Weekly Report, February 14, 2022
• Development and Validation of the HIV-IMP Risk Score Is this newly developed risk score a valid means of predicting in-hospital mortality in HIV patients?
  HIV Medicine, February 10, 2022
• Same-Day ART Initiation for People With HIV With TB Symptoms Should people with HIV exhibiting tuberculosis symptoms be started on same-day antiretroviral therapy? A new review looks at the risks and benefits of this strategy.
  HIV Medicine, January 27, 2022
• Immunotherapeutic Approaches to HIV Cure and Remission Recent advances have led to developments in immunotherapeutic approaches towards HIV remission or cure.
  Current Opinion in Infectious Diseases, January 10, 2022
• HIV PrEP Awareness Among Hispanic/Latino Persons How aware are Hispanics and Latinos of the availability of preexposure prophylaxis as a strategy to prevent HIV infection? How often are they referred for PrEP?
  Morbidity & Mortality Weekly Report, December 24, 2021
• SARS-CoV-2 Infection Among People With and Without HIV In what ways do the symptoms, severity, and outcomes of SARS-CoV-2 infection differ between people with and without HIV?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, December 24, 2021
• TNF-a Inhibition in the Setting of Undiagnosed HIV Infection Should patients be routinely screened for HIV prior to starting biologic medications? This paper explores the issue.
  AIDS, December 17, 2021
• High Rate of Long-Term Events After ART Resumption in HIV HIV patients who experienced ART interruption may be at a greater risk for long-term events after treatment resumption.
  AIDS, November 30, 2021
• A HIV PrEP Service Tailored to People Who Inject Drugs Could this approach to PrEP care help improve uptake among this vulnerable population?
  HIV Medicine, November 22, 2021
• Renal Impairment in a HIV PrEP Implementation Cohort How likely is TDF-containing HIV PrEP to impact renal function, and what are the risk factors? A large-scale implementation study investigates.
  AIDS, November 18, 2021
• Outcomes Among Persons With HIV With Suspected SARS-CoV-2 What have we learned about the clinical characteristics and outcomes of people with HIV and SARS-CoV-2 infection? A study of emergency department patients provides some insight.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, November 17, 2021